Announcement on Completion of Election of New Board of Directors and Appointment of Senior Executive and Securities Affairs Representative
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(688806)"ZHUHAI TRINOMAB PHARMACEUTICAL CO., LTD."Announcement on Completion of Election of New Board of Directors and Appointment of Senior Executive and Securities Affairs Representative
Filed with SSE · Stock code 688806 · · 5 pages · Chinese
Summary by 6ix AI
Zhuhai Trinomab Pharmaceutical Co., Ltd. has announced the completion of its board of directors' election and the appointment of senior executives and a securities affairs representative. The company held a shareholder meeting to elect the second board of directors and subsequently convened a board meeting to elect the chairman and vice chairman. New senior management appointments include a general manager, chief technology officer, and chief medical officer, among others. The announcement also notes the departure of certain board members following the election.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Release
Zhuhai Trinomab Pharmaceutical Co., Ltd. on 6ix
Follow Zhuhai Trinomab Pharmaceutical into a list and get an email when it puts out news.
Follow Zhuhai Trinomab Pharmaceutical